GLP-1 weight loss drugs and the ongoing advances in the AI sphere are currently two of the biggest thematic plays that Wall Street is relentlessly championing, facilitating a phenomenal influx of capital in companies that are seen as beneficiaries of the upheaval that the proponents of these nascent technologies argue is just around the proverbial corner. Recently, GLP-1 drugs from the likes of Novo Nordisk (NVO) and Eli Lilly and Company (LLY) have been billed as a blessing in disguise for the airline industry and a harbinger of doom for the fast food sector. Can a single drug really induce […]
Read full article at https://wccftech.com/will-glp-1-weight-loss-drugs-allow-airlines-to-save-millions-of-dollars-and-tank-the-fast-food-industry-here-are-the-numbers-so-far/
WccftechContinue reading/original-link]